409
Views
53
CrossRef citations to date
0
Altmetric
Research Article

Effects of Probucol on Endothelial Damage by 5-Fluorouracil

, , &
Pages 304-308 | Published online: 08 Jul 2009

  • Robben FR, Pippas A, Moore J. The syndrome of 5-fluorouracil cardiotoxicity. Cancer 1993; 71: 493-509.
  • Labianca R, Berreta G, Clerici M, Fraschini P, Luporini G. Cardiac toxidty of 5-fluorouracil: a study on 1 083 patients. Tumori 1982; 68: 505-10.
  • Becker K, Erckenbrech F, Hausing D, Frieling T. Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs 1999; 57: 475-84.
  • Cwikiel M, Eskilsson J, Wieslander JB, Stjernqvist U, Albertsson M. The appearance of endothelium in small arteries after the treatment with 5-fluorouracil. An electron microscopic study of its late effects in rabbits. Scanning Microsc 1996; 10: 805-20.
  • Cwikiel M, Albertsson M, Eskilsson J, Stavenov L. The influence of 5-fluorouracil and methotrexate on vascular endothelium. An experimental study using endothelial cells in culture. Ann Oncol 1996; 7: 731-7.
  • Kehrer JP. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 1993; 23: 21-48.
  • Buckley M, Goa KL, Price AH, Brogden RN. Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia. Drugs 1989; 37: 761-800.
  • Siveski-Iliscovic N, Hill M, Chow DA, Singal PK. Protocol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 1995; 91: 10-5.
  • Li T, Danelisen I, Bello-Klein A, Singal PK. Effects of probucol on changes of antioxidant enzymes in adriamycininduced cardiomyopathy in rats. Cardiovasc Res 2000; 46: 52330.
  • Zapolska-Downar D, Zapolski-Downar A, Markiewski M, Ciechanowicz A, Kaczmarczyk M, Naruszewicz M. Selective inhibition by probucol of vascular cell adhesion molecule-1 (VCAM-I) expression in human vascular endothelial cells. Atherosclerosis 2001; 155: 123-30.
  • Jiang JL, Li NS, U YJ, Deng HW. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Br J Pharmacol 2002; 135: 1175-82.
  • Witztum JL, Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med 2001; 11: 93-102.
  • Wieslander JB, Stjernqvist U. The influence of non-ionic contrast media on the endothelium of small arteries. Acta Radiol Suppl 1987; 370: 73-7.
  • Durak I, Karaayvaz M, Kavutcu M, et al. Reduced antioxidant defense capacity in myocardial tissue from guinea pigs treated with 5-fluorouracil. J Toxicol Environ Health 2000; 59: 585-9.
  • Jung ID, Yang SY, Park CO, et al. 5-Fluorouracil inhibits nitric oxide production through the inactivation of I kappa B kinase in stomach cancer cells. Biochem Pharmacol 2002; 64: 143945.
  • Matthews NE, Adams MA, Maxwell LR, Gofton TE, Graham CH. Nitic oxide-mediated regulation of chemosensitivity in cancer cells. J Natl Cancer Inst 2001; 93: 1879-85.
  • Oshima T, Imada T, Nagashima Y, et al. Role of nitric oxide in human gastric cancer cells treated with 5-fluorouracil. Oncol Rep 2001; 8: 847-9.
  • Stathopoulos GP, Malamos NA, Dontas I, Deliconstantinos G, Perrea-Kotsareli D, Karayannacos PE. Inhibition of adriamycin cardiotoxicity by 5-fluorouracil: a potential free oxygen radical scavenger. Anticancer Res 1998; 18: 4387-92.
  • Jin Y, Heck DE, DeGeorge F, Tian Y, Laskin JD. 5Fluorouracil suppresses nitric oxide biosynthesis in colon carcinoma cells. Cancer Res 1996; 56: 1978-82.
  • Ruef J, Peter K, Nordt TK, Runge MS, Kübier W, Bode C. Oxidative stress and atherosclerosis: its relationship to growth factors, thrombus formation and therapeutic approaches. Thromb Haemost 1999; 82(Suppl): 32-7.
  • Reinoehl J, Frankovich D, Machado C, et al. Probucolassociated tachyarrhythmic events and QT prolongation: importance of gender. Am Heart J 1996; 131: 1184-91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.